Flash-Player installieren
ScheBo-MediaBox



» Flash-Player installieren
» Watch video in bigger size

ScheBo® · Biotech AG
Netanyastrasse 3
35394 Giessen
Germany

Phone +49 (0)641 / 4996-0
Fax +49 (0)641 / 4996-77
Email-contact

General information

The first test for the quantification of canine faecal elastase 1 indicated in suspicion of pancreatic exocrine insufficiency.


The pancreas of dogs secretes a digestive enzyme that is homologous to human pancreatic elastase 1. Canine pancreatic elastase 1 (E1) remains undegraded during intestinal transit. Therefore its faecal concentration reflects pancreatic exocrine function.

To improve the diagnosis of canine pancreatic exocrine insufficiency ScheBo® Biotech have developed a species-specific enzyme immunoassay (ELISA) that allows quantification of pancreatic elastase1 in the faeces of dogs. This ELISA is based on canine-specific monoclonal antibodies and allows diagnosis or exclusion of pancreatic exocrine insufficiency in dogs, which is mainly due to pancreatic acinar atrophy, chronic pancreatitis or the disturbed flow of pancreatic juice.

Quantification of human pancreatic elastase 1 in faeces has proven to be a superior non-invasive pancreatic function test for the diagnosis of pancreatic exocrine insufficiency with a sensitivity and specificity of 93%. Its results correlate well with the invasive gold standard secretin-pancreozymin test. The ScheBo® Elastase 1 - Canine test promises to deliver similar reliability in measuring canine exocrine function.



AEO-Certificate
The Main Customs Office of Giessen, Germany issued an AEO-F Certificate (Authorized Economic Operator – Customs Simplifications plus Security and Safety) to ScheBo Biotech AG on September 30, 2011.
read...
Lecture DDW 2011: New molecular markers: M2-PK
Lecture of Prof. Dr. Sybille Mazurek on WEO/OMED Colorectal Cancer Screening Committee Meeting DDW 2011.
read...
Biomarker ′M2-PK′ Identified as Key Enzyme in Cancer Diagnosis and Therapy
Ground Breaking Findings on Understanding Cancer Published in ′Science′
read...
Video: Focus 2010 lecture on M2-PK
The high sensitivity (c.80%) and high specificity (>90%) of the M2-PK stool test for colorectal cancer screening and detection, plus benefits for patients, laboratories and doctors, was presented at Focus 2010
read...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
read...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
read...
ISO-Certificate
Our ISO-Cerficate as pdf-download.
read...